CUSIP: 29604W108
What is CUSIP 29604W108?
CUSIP 29604W108 identifies PHXM - ERYTECH PHARMA - SPONSORED ADR in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 29604W108:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q3 | 0 | $0 | -$96,798 | 0 | |
| 2023 Q2 | 135,763 | $99,055 | -$185,407 | $0.74 | 9 |
| 2023 Q1 | 373,376 | $374,405 | +$20,262 | $0.98 | 9 |
| 2022 Q4 | 741,962 | $244,803 | -$503,703 | $0.33 | 8 |
| 2022 Q3 | 1,482,063 | $782,000 | -$14,233 | $0.55 | 8 |
| 2022 Q2 | 1,503,746 | $1,651,000 | -$3,333,017 | $1.11 | 6 |
| 2022 Q1 | 3,351,792 | $5,969,000 | -$1,552,951 | $1.82 | 5 |
| 2021 Q4 | 4,223,322 | $9,942,000 | +$2,962,490 | $2.36 | 9 |
| 2021 Q3 | 2,011,390 | $11,608,000 | +$370,892 | $5.89 | 10 |
| 2021 Q2 | 1,946,556 | $9,429,000 | +$3,287,789 | $4.87 | 4 |
| 2021 Q1 | 1,261,343 | $8,950,000 | -$26,000 | $7.14 | 3 |
| 2020 Q4 | 1,260,926 | $11,995,000 | -$43,217 | $9.79 | 4 |
| 2020 Q3 | 1,265,342 | $7,752,000 | -$267,000 | $6.25 | 3 |
| 2020 Q2 | 1,298,293 | $11,378,000 | -$300,206 | $8.41 | 4 |
| 2020 Q1 | 1,335,342 | $7,123,000 | $5.34 | 4 | |
| 2019 Q4 | 1,335,342 | $9,781,000 | -$539,353 | $7.31 | 4 |
| 2019 Q3 | 1,455,419 | $6,302,000 | -$14,199 | $4.44 | 5 |
| 2019 Q2 | 1,458,619 | $10,432,000 | -$29,064 | $7.15 | 5 |
| 2019 Q1 | 1,462,682 | $11,100,000 | -$7,583 | $7.58 | 5 |
| 2018 Q4 | 1,463,682 | $9,905,000 | -$9,978,047 | $6.77 | 5 |
| 2018 Q3 | 2,631,032 | $22,655,000 | -$16,846,238 | $8.64 | 8 |
| 2018 Q2 | 4,599,557 | $51,637,000 | -$880,554 | $11.17 | 7 |
| 2018 Q1 | 4,573,446 | $96,044,000 | -$670,437 | $21.00 | 8 |
| 2017 Q4 | 4,603,787 | $101,378,000 | +$99,839,000 | $22.02 | 10 |